Home
About Us
Help and Support
Subscribe
Company Analyst
Financial Analyst
Pipeline Analyst
Archives
Tools
Log In
Print this
RP5063
print preview
bookmark
share with colleague
General Information
Company
Reviva Pharmaceuticals Inc.
Description
Partial agonist of the dopamine D2, D3 and D4 receptors and the serotonin 5-HT1A and 5-HT2A receptors, and antagonist of the serotonin 5-HT6 and 5-HT7 receptors
Molecular Target
Dopamine D2 receptor
;
Serotonin (5-HT1A) receptor
Mechanism of Action
Latest Stage of Development
Phase II
Indication
Schizophrenia
Partner
Product Summary: Number of Indications in each Phase of Development by Disease Category
More
Product Details
Archive Items are loading
Set Email Alert
dummy